The use of Esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial
@article{ATM97171,
author = {Yanbing Su and Jianxing Zhang and Huanwei Wang and Yangkui Gu and Handong Ouyang and Wan Huang},
title = {The use of Esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial},
journal = {Annals of Translational Medicine},
volume = {10},
number = {12},
year = {2022},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/97171}
}